1. Home
  2. HALO vs ORI Comparison

HALO vs ORI Comparison

Compare HALO & ORI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$108.26

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Logo Old Republic International Corporation

ORI

Old Republic International Corporation

N/A

Current Price

$41.15

Market Cap

9.8B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
HALO
ORI
Founded
1998
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
9.8B
IPO Year
2001
1994

Fundamental Metrics

Financial Performance
Metric
HALO
ORI
Price
$108.26
$41.15
Analyst Decision
Buy
Buy
Analyst Count
11
2
Target Price
$78.64
$43.50
AVG Volume (30 Days)
1.4M
962.2K
Earning Date
05-05-2026
04-23-2026
Dividend Yield
N/A
9.47%
EPS Growth
N/A
14.81
EPS
3.11
2.63
Revenue
$151,862,000.00
$9,136,300,000.00
Revenue This Year
$28.24
$7.07
Revenue Next Year
$12.56
$6.86
P/E Ratio
$34.47
$15.57
Revenue Growth
N/A
10.99
52 Week Low
$61.23
$36.65
52 Week High
$111.15
$46.76

Technical Indicators

Market Signals
Indicator
HALO
ORI
Relative Strength Index (RSI) 64.98 46.73
Support Level $103.47 $41.33
Resistance Level $111.15 $42.88
Average True Range (ATR) 2.33 0.63
MACD -1.06 -0.11
Stochastic Oscillator 59.05 44.77

Price Performance

Historical Comparison
HALO
ORI

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About ORI Old Republic International Corporation

Old Republic International Corp is engaged in the business of insurance underwriting and related services. The company operates in two segments: Specialty Insurance and Title Insurance. The insurance provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others. The company generates the majority of its revenue from Specialty Insurance. The Specialty Insurance provides property and liability insurance principally to commercial clients.

Share on Social Networks: